ViewFunders fear return to ‘fragmented’ disease research

Pandemic cooperation could wither due to “Infectious Nationalism” or back to normal scenarios, says Glopid-R

ViewInterview: Curiosity’s champion

Three-time European Research Council president Jean-Pierre Bourguignon on funding, his successor and his legacy

ViewResearch leaders blast proposed R&D cut

Member state governments’ move to slash EU funding labelled “extremely disappointing”, especially in “unusual” times

ViewBack to normal?

At the dawn of the academic year, EU Covid funds offer hope

ViewInside out

Back page gossip from the 16 September issue of Research Europe

ViewFrom our correspondents: Road to recovery

The first payments from the EU’s enormous pandemic recovery fund have triggered mixed reactions

ViewChange at the top

The Department for Education has a new secretary of state

ViewReturn to campus does not mean return to normal

The pandemic’s profound but uneven impacts require both local and sector-wide action, says Petra Boynton

ViewNadhim Zahawi takes over at education department

Former vaccines minister replaces Gavin Williamson as secretary of state as UK government reshuffle continues

ViewAgenda-setting speech promises ‘state of the art’ EU microchips

But European Commission president Ursula von der Leyen leaves research leaders wanting more

ViewConsultation starts on Paris healthcare campus

Two-month programme of public debate to determine PariSanté’s research focus

ViewNew Zealand news roundup: 9-15 September

This week: grant delays, extra student support and the appointment of a mātauranga Māori professor

ViewTax returns

There is growing pressure on university budgets and graduate pay packets

ViewGive science a voice at the General Assembly

The UN must explicitly recognise science’s role in combating global challenges, says Magdalena Skipper

ViewHigh vaccination rate among Berlin students

Survey shows eagerness to get two Covid-19 jabs as universities restart campus education

ViewGermany news round-up: 8-14 September

This week: an Erasmus+ windfall, a call for UK cooperation and funds for ‘weak’ regions

View‘Victory for common sense’ as ARC backs down on preprints

Australian Research Council ends preprint ban, but change will not apply to current rounds

ViewYearnings not earnings

How can time at university be valued beyond a measure of graduate salaries?

ViewLiverpool launches institute to prepare for future pandemics

Institute initially funded by £10 million gift from giant global provider of rapid Covid-19 tests

ViewUKRI response to Black academics ‘missed critical points’

Research funder “sparse” on plans to engage with marginalised scholars, say co-authors of critical letter

ViewUK is still ‘committed’ to 2.4% R&D target pledge

Government insists key R&D commitments are still intact, despite breaking other manifesto promises

ViewUCU pushes climate fight and three-day weekend

Union’s head Jo Grady calls for unity between workers at major trade union conference

ViewAppeal slams GDPR clampdown on Danish health data

Leaders of clinical institutions ask politicians to take back control from EU lawyers

ViewWe need to talk about Gavin

Universities need friends in government, but who will speak for them now?

ViewBack to campus

Nick Hillman reflects on meeting university leaders in person after a tricky year

ViewMPs denounce ‘short-sighted’ cuts for British Council

Axed funding means job cuts and office closures at British Council, but government defends support

ViewCambridge University researchers scoop ‘Oscars for science’

Several UK-based researchers were among the winners of the 2022 Breakthrough and New Horizons prizes

ViewBritish Heart Foundation, ESRC policy scheme, Poland’s international fellowships, applying to the Smithsonian

A roundup of this week’s Funding Insight articles

ViewPot and kettle

The Netherlands supported strict conditions for EU Covid-19 recovery funds—but it cannot meet them

ViewNetherlands news roundup: 4-10 September

This week: prestigious prizes, open-access publication growth and free licences to use patented Crispr-Cas technology